AKKARAJU SRINIVAS 4

What Happened Srinivas Akkaraju, a director of ALUMIS, was granted two awards on 2026-06-30: 3,553 shares (RSUs) and 15,528 derivative shares, each recorded at $0.00 per share (total reported value $0). The RSU award is subject to vesting; the second line reflects a derivative award/holding related to entities tied to the Reporting Person.

Key Details

• Transaction date: 2026-06-30; Form 4 filed 2026-07-02 (appears timely for the 2-business-day Form 4 window).
• Prices: $0.00 per share for both line items; total reported cash consideration = $0.
• Vesting for the 3,553 RSUs: vest on first anniversary of grant, or fully vest by the Issuer's 2027 annual meeting, subject to continuous service; vest in full upon a Change in Control (per footnote).
• The 15,528 "derivative" shares are associated with entities (Samsara BioCapital LP and Samsara Opportunity Fund) described in the filing; the Reporting Person is a managing member/has voting & investment power but disclaims beneficial ownership except to the extent of his pecuniary interest.
• Shares owned after the transaction are not specified in the excerpt provided — see the full Form 4 for total beneficial ownership counts and holdings breakdown.

Context

• The 3,553-item is an RSU award (restricted stock unit) that converts to common shares when vested; this is a compensation award rather than an open-market purchase or sale. RSU vesting terms (time-based and change-in-control) are noted on the filing.
• The 15,528 entry involves securities held by investment vehicles connected to the Reporting Person; such entries often reflect holdings controlled through funds and include disclaimers of direct beneficial ownership.
• Awards like these are routine forms of executive/director compensation and do not, by themselves, indicate the insider is buying or selling stock for immediate market exposure. Check the full Form 4 for ownership totals and any additional footnotes.